Physician profile
Mark A Hilger
NPI 1033121041
$1,841.28
in general payments reported to CMS, 2019-2025
19 companies · $165 in 2025
The $165 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $841 · 2020: $133 · 2021: $430 · 2022: $235 · 2023: $16.24 · 2024: $20.61 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $402.69 | 2019-2022 | |
| Pfizer INC. | $252.99 | 2019-2025 | |
| Amgen INC. | $220.07 | 2019-2021 | |
| Medtronic, INC. | $151.44 | 2025 | Intellis Adaptivestim, Symplicity G3 |
| Merck Sharp & Dohme LLC | $149.18 | 2019-2020 | |
| Esperion Therapeutics, INC. | $125.80 | 2021 | |
| Lilly USA, LLC | $111.17 | 2019-2022 | |
| Astellas Pharma US INC | $76.55 | 2019-2021 | |
| Novo Nordisk INC | $57.16 | 2019-2023 | Ozempic, Rybelsus |
| Nevro Corp. | $48.88 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $47.38 | 2019-2021 | |
| Eisai INC. | $47.18 | 2021 | |
| Abbvie INC. | $39.26 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $24.44 | 2019-2020 | |
| Cranial Technologies, INC | $20.61 | 2024 | Doc Band |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.59 | 2020 | |
| Sunovion Pharmaceuticals INC. | $17.59 | 2021 | |
| Shire North American Group INC | $14.55 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Hilger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.